BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 25674244)

  • 1. 'Stanniocalcin 2 expression is associated with a favourable outcome in male breast cancer'.
    J Pathol Clin Res; 2019 Jul; 5(3):213. PubMed ID: 31334921
    [No Abstract]   [Full Text] [Related]  

  • 2. Decreased expression of ABAT and STC2 hallmarks ER-positive inflammatory breast cancer and endocrine therapy resistance in advanced disease.
    Jansen MP; Sas L; Sieuwerts AM; Van Cauwenberghe C; Ramirez-Ardila D; Look M; Ruigrok-Ritstier K; Finetti P; Bertucci F; Timmermans MM; van Deurzen CH; Martens JW; Simon I; Roepman P; Linn SC; van Dam P; Kok M; Lardon F; Vermeulen PB; Foekens JA; Dirix L; Berns EM; Van Laere S
    Mol Oncol; 2015 Jun; 9(6):1218-33. PubMed ID: 25771305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stanniocalcin 2 (STC2): a universal tumour biomarker and a potential therapeutical target.
    Qie S; Sang N
    J Exp Clin Cancer Res; 2022 May; 41(1):161. PubMed ID: 35501821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of high stanniocalcin 2 expression in solid cancers: A meta-analysis.
    Hu L; Zha Y; Kong F; Pan Y
    Medicine (Baltimore); 2019 Oct; 98(43):e17432. PubMed ID: 31651846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of STC2 in colorectal cancer and its clinicopathological significance.
    Zhang C; Chen S; Ma X; Yang Q; Su F; Shu X; Xie W; Feng M; Xiong B
    Onco Targets Ther; 2019; 12():1249-1258. PubMed ID: 30863092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stanniocalcin-2 May Be a Potentially Valuable Prognostic Marker in Endometrial Cancer: a Preliminary Study.
    Aydin HA; Toptas T; Bozkurt S; Aydin A; Erdogan G; Pestereli E; Simsek T
    Pathol Oncol Res; 2019 Apr; 25(2):751-757. PubMed ID: 30661222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarkers could facilitate prediction of worse clinical outcome of cancer with special insight to cervical cancer.
    Czerniak B; Olszewska-Słonina D
    Contemp Oncol (Pozn); 2018; 22(1):1-7. PubMed ID: 29692656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-184 Retarded the Proliferation, Invasiveness and Migration of Glioblastoma Cells by Repressing Stanniocalcin-2.
    Feng L; Ma J; Ji H; Liu Y; Hu W
    Pathol Oncol Res; 2018 Oct; 24(4):853-860. PubMed ID: 28887636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive molecular exploration identified promoter DNA methylation of the CRBP1 gene as a determinant of radiation sensitivity in rectal cancer.
    Yokoi K; Yamashita K; Ishii S; Tanaka T; Nishizawa N; Tsutsui A; Miura H; Katoh H; Yamanashi T; Naito M; Sato T; Nakamura T; Watanabe M
    Br J Cancer; 2017 Apr; 116(8):1046-1056. PubMed ID: 28291773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and Validation of Reference Genes for RT-qPCR Studies of Hypoxia in Squamous Cervical Cancer Patients.
    Fjeldbo CS; Aarnes EK; Malinen E; Kristensen GB; Lyng H
    PLoS One; 2016; 11(5):e0156259. PubMed ID: 27244197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relevance of molecular biomarkers in cervical cancer patients treated with radiotherapy.
    Kilic S; Cracchiolo B; Gabel M; Haffty B; Mahmoud O
    Ann Transl Med; 2015 Oct; 3(18):261. PubMed ID: 26605307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of estrogen receptor alpha in human cervical cancer-associated fibroblasts: a transcriptomic study.
    Kumar MM; Davuluri S; Poojar S; Mukherjee G; Bajpai AK; Bafna UD; Devi UK; Kallur PP; Kshitish AK; Jayshree RS
    Tumour Biol; 2016 Apr; 37(4):4409-20. PubMed ID: 26499945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Five years' experience treating locally advanced cervical cancer with concurrent chemoradiotherapy and high-dose-rate brachytherapy: results from a single institution.
    Parker K; Gallop-Evans E; Hanna L; Adams M
    Int J Radiat Oncol Biol Phys; 2009 May; 74(1):140-6. PubMed ID: 18922646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lgr5 is a potential prognostic marker in patients with cervical carcinoma.
    Sun B; Ye X; Li Y; Zhang W
    Int J Clin Exp Pathol; 2015; 8(2):1783-9. PubMed ID: 25973068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High expression of flotillin-2 is associated with poor clinical survival in cervical carcinoma.
    Liu Y; Lin L; Huang Z; Ji B; Mei S; Lin Y; Shen Z
    Int J Clin Exp Pathol; 2015; 8(1):622-8. PubMed ID: 25755754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The significance of Stanniocalcin 2 in malignancies and mechanisms.
    Li S; Huang Q; Li D; Lv L; Li Y; Wu Z
    Bioengineered; 2021 Dec; 12(1):7276-7285. PubMed ID: 34612765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiotherapy and anaemia--the clinical experience.
    Dische S
    Radiother Oncol; 1991; 20 Suppl 1():35-40. PubMed ID: 2020767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of stanniocalcin 2 is associated with tumor progression after radiotherapy in patients with cervical carcinoma.
    Shen XJ; Gu K; Shi JP; Yao JQ; Wu JC
    Int J Clin Exp Pathol; 2014; 7(12):8770-6. PubMed ID: 25674244
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.